145319-03-5

Basic information

• Product Name: 2-butyl-4-chloro-1,6-dihydro-6-methyl-1-<<2'-<1-(triphenylmethyl)tetrazole-5-yl><1,1'-biphenyl>-4-yl>methyl>pyrimidine-5-carboxylic acid, diphenylmethyl ester
• Synonyms: 2-butyl-4-chloro-1,6-dihydro-6-methyl-1-<<2'-<1-(triphenylmethyl)tetrazole-5-yl><1,1'-biphenyl>-4-yl>methyl>pyrimidine-5-carboxylic acid, diphenylmethyl ester
• CAS NO: 145319-03-5
• Molecular Weight: 873.497
• Mol File: 145319-03-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-butyl-4-chloro-1,6-dihydro-6-methyl-1-<<2'-<1-(triphenylmethyl)tetrazole-5-yl><1,1'-biphenyl>-4-yl>methyl>pyrimidine-5-carboxylic acid, diphenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-butyl-4-chloro-1,6-dihydro-6-methyl-1-<<2'-<1-(triphenylmethyl)tetrazole-5-yl><1,1'-biphenyl>-4-yl>methyl>pyrimidine-5-carboxylic acid, diphenylmethyl ester(145319-03-5)
• EPA Substance Registry System: 2-butyl-4-chloro-1,6-dihydro-6-methyl-1-<<2'-<1-(triphenylmethyl)tetrazole-5-yl><1,1'-biphenyl>-4-yl>methyl>pyrimidine-5-carboxylic acid, diphenylmethyl ester(145319-03-5)

Safety Data

• Hazardous Substances Data: 145319-03-5(Hazardous Substances Data)

Upstream product

• 908093-98-1 diazodiphenylmethane 
• 142385-30-6 6-butyl-4-chloro-1-<2'-<(1,1-dimethylethoxy)carbonyl><1,1'-biphenyl>-4-yl>-1,2-dihydro-2-methyl-3-pyrimidinecarboxylic acid, ethyl ester 
• 142385-21-5 2-butyl-1-<<2'-carboxy<1,1'-biphenyl>-4-yl>methyl>-4-chloro-1,6-dihydro-6-methylpyrimidine-5-carboxylic acid, ethyl ester 
• 142385-29-3 6-butyl-4-chloro-1,2-dihydro-2-methyl-3-pyrimidinecarboxylic acid, ethyl ester 
• 145319-01-3 2-butyl-1-<<2'-carboxy<1,1'-biphenyl>-4-yl>methyl>-4-chloro-1,6-dihydro-6-methyl-5-pyrimidinecarboxylic acid 
• 124750-51-2 N-(triephenylmethyl)-5-<4'-(bromomethyl)-biphenyl-2-yl>tetrazole 
• 145319-02-4 2-butyl-1-<<2'-carboxy<1,1'-biphenyl>-4-yl>methyl>-4-chloro-1,6-dihydro-6-methyl-5-pyrimidinecarboxylic acid 

Relevant articles and documents

Dihydropyrimidine Angiotensin II Receptor Antagonists

The discovery of the nonpeptidic angiotensin II (AII) receptor antagonist losartan (1), previously called DuP 753, has stimulated considerable interest in the synthesis of novel analogs of this compound.Our efforts in this urea have resulted in the discov